2015
DOI: 10.1134/s1062359015010057
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitors of neuronal and inducible nitric oxide synthase enhance the protective effect of short-term adaptation to hypoxia in Krushinsky-Molodkina rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…However, if the concentration of NO or • O is reduced with the help of NO synthase inhibitors, NO traps (for example, diethyldithiocarbamate– disulfiram) and/or inhibitors of free radical processes involving NO or • O , then it is possible to influence almost all pathological processes occurring against the background of hypoxia/ischemia, inflammatory processes and the activation of immune/autoimmune processes. We have every reason to believe that the same processes and mechanisms develop when solving both problems associated with hemorrhagic and ischemic strokes [ 181 – 187 ], as well as problems of tissue engineering structures, which include the creation of a new center of local neurohumoral regulation based on the formation of new nervous and vascular connections [ 41 – 57 ]. Therefore, we hypothesize that using inhibitors of NO synthase, NO traps (such as diethyldithiocarbamate) and/or inhibitors of free radical processes involving NO or • O , makes it possible to reduce the number of deaths in those 5–30% of cases when the development of destructive changes is observed in the displaced ganglion.…”
Section: Discussionmentioning
confidence: 99%
“…However, if the concentration of NO or • O is reduced with the help of NO synthase inhibitors, NO traps (for example, diethyldithiocarbamate– disulfiram) and/or inhibitors of free radical processes involving NO or • O , then it is possible to influence almost all pathological processes occurring against the background of hypoxia/ischemia, inflammatory processes and the activation of immune/autoimmune processes. We have every reason to believe that the same processes and mechanisms develop when solving both problems associated with hemorrhagic and ischemic strokes [ 181 – 187 ], as well as problems of tissue engineering structures, which include the creation of a new center of local neurohumoral regulation based on the formation of new nervous and vascular connections [ 41 – 57 ]. Therefore, we hypothesize that using inhibitors of NO synthase, NO traps (such as diethyldithiocarbamate) and/or inhibitors of free radical processes involving NO or • O , makes it possible to reduce the number of deaths in those 5–30% of cases when the development of destructive changes is observed in the displaced ganglion.…”
Section: Discussionmentioning
confidence: 99%